TrialPloS one2010

Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine.

Sandhya Vasan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.